Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Iho-ihokosketus synnytyssalista vastasyntyneiden teho-osastolle siirron aikana: Vaikutus hyvin keskosille ja heidän vanhemmilleen (TRANSPAPNEO)

keskiviikko 4. marraskuuta 2026 päivittänyt: University Hospital, Tours

Iho-ihokosketuksen arviointi hyvin keskosten siirron aikana synnytyshuoneesta vastasyntyneiden tehohoitoyksikköön: satunnaistettu, kontrolloitu, ei-alempi, avoin koe verrattuna siirtoon inkubaattorissa

Developmental care are recognized as a standard of care for preterm infants in neonatal intensive care units. Regular skin-to skin contacts during the neonatal stay show short and long-term beneficial effects on preterm infants and their parents. Skin-to-skin contact provides hemodynamic and thermal stability in preterm infants. Regarding parents, skin-to-skin contact sustains the parental bonding, and reduces stress and anxiety related to hospitalization. As a result, early skin-to-skin contact has been associated with an improvement of neurological outcome in very preterm infants.

Thermal stability is crucial during the first hour of life in preterm infants. A temperature at admission in the neonatal intensive care unit below 36.5°C or above 37.2°C has been associated with an increase in neonatal morbidity and mortality.

Early skin-to-skin contact between a newborn and his/her mother in the delivery room significantly decreases the occurrence of hypothermia below 35.5°C.

The practice of skin-to-skin transfer from the delivery room is emerging in France. Pilot studies have been carried out by French neonatal teams that showed the feasibility of this practice in late-preterm, near-term and term infants. Although skin-to-skin contact routinely involves very preterm infants in neonatal intensive care units worldwide, the feasibility and safety of skin-to-skin contact during the transfer from delivery room to the neonatal unit is poorly documented in very preterm infants. Previous data of our team showed that transfer of preterm infants with non-invasive ventilation using skin-to-skin contact was feasible and safe but concerns emerged about the thermal conservation during the procedure.

The main hypothesis of this study is that skin-to skin contact during the transfer from the delivery room to the neonatal intensive care unit could prevent heat losses in preterm infants as well as the transfer in incubator. Another hypothesis is that very early skin-to-skin contact could positively influence the neonatal course and the parental experience in the neonatal care unit.

Tutkimuksen yleiskatsaus

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

118

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

      • Angers, Ranska, 49000
        • CHU Angers
      • Orléans, Ranska, 45000
        • Neonatal medicine and intensive care unit, University Hospital, Orléans
      • Toulouse, Ranska, 31300
        • Neonatology service, University Hospital, Toulouse
      • Tours, Ranska, 37000
        • Neonatal and paediatric service, University Hospital, Tours

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

5 kuukautta - 7 kuukautta (Lapsi)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Gestational age < 34 weeks
  • Singleton pregnancy
  • Inborn birth, i.e., in the maternity ward of investigating centres
  • Need of hospitalization in the neonatal intensive care unit
  • Oral and written information of parents and written parental consent to participate in the study (by the father if the mother is unable to participate)

Exclusion Criteria:

  • Single parent or homosexual couple
  • Absence of the father in the delivery room
  • Parents not speaking French
  • Skin temperature of the newborn < 36°C at the time of randomization
  • Conditions not allowing the early skin-to-skin contact: omphalocele, gastroschisis, desquamating dermatological conditions (Harlequin syndrome, Collodion)
  • Clinical condition requiring a specific transfer mode according to the pediatrician in the delivery room
  • Parents under legal protection
  • Minor parents

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Muut
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Skin-to-skin contact during the transfer between the delivery room and the neonatal care unit

Preterm infants will be transferred using a direct skin-to-skin contact with their father from the delivery room to the intensive neonatal care.

For the Skin-to-skin Contact (SSC) transfer, the bare-chested father will seat in a wheelchair. Newborns who will wear only a diaper and a cotton cap or noninvasive ventilation headgear will be placed in the kangaroo position against the father's chest to ensure direct contact with the father's skin. Preterm infants with gestational age less than 33 weeks will be wrapped with their father using plastic bags plus warmed cotton towels. More gestationally mature infants will be wrapped with only warmed cotton wraps. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

Active Comparator: Transfer in incubator between the delivery room and the neonatal care unit

Preterm infants will be transferred in an incubator set to 36°C from the delivery room to the intensive neonatal care.

In the incubator group, infants will be transferred after resuscitation in an incubator with air temperature set to 36°C. The newborn will be laid on his/her back in a polyethylene bag with a cap. The newborn's heart rate, oxygen saturation and skin temperature will be monitored throughout the procedure.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in the infant skin temperature due to the transfer procedure
Aikaikkuna: During the transfer procedure

Fluctuation in the infant skin temperature between the randomization in the delivery room and the admission in the neonatal intensive care unit (NICU)

During the transfer procedure

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Change in the infant's heart rate during the transfer procedure
Aikaikkuna: During the transfer procedure

Heart rate values during the transfer procedure

During the transfer procedure
Occurrence of bradycardia episodes in infant during the transfer procedure
Aikaikkuna: During the transfer procedure

Rapid decrease in heart rate less than 100 beats/min that lasts at least 10 secondes during the transfer procedure

During the transfer procedure
Change in the infant's oxygen saturation during the transfer procedure
Aikaikkuna: During the transfer procedure

Oxygen saturation values during the transfer procedure

During the transfer procedure
Occurrence of desaturation episodes in infant during the transfer procedure
Aikaikkuna: During the transfer procedure

Decrease in oxygen saturation less than 85% that last at least 10 secondes

During the transfer procedure
Change in the infant's fraction of inspired oxygen during the transfer procedure
Aikaikkuna: During the transfer procedure

Fraction of inspired oxygen values during the transfer procedure

During the transfer procedure
Duration of the transfer procedure
Aikaikkuna: During the transfer procedure

Time (in min) during the transfer procedure

During the transfer procedure
First Hydrogen Potential (pH) of the newborn
Aikaikkuna: First blood gas in the NICU

First assessment of pH in the neonatal intensive care unit (NICU)

First blood gas in the NICU
Carbon dioxide partial pressure (pCO2) of the newborn
Aikaikkuna: First blood gas in the NICU

First assessment of carbon dioxide partial pressure (pCO2) in the neonatal intensive care unit (NICU)

First blood gas in the NICU
Blood glucose of the newborn
Aikaikkuna: First blood glucose measurement in the NICU

First assessment of blood glucose in the neonatal intensive care unit (NICU)

First blood glucose measurement in the NICU
Occurence of hypothermia
Aikaikkuna: From admission in the neonatal intensive care unit to 30 min later

Decrease of skin temperature less than 36°C

From admission in the neonatal intensive care unit to 30 min later
Time to the first skin-to-skin contact in the neonatal care unit
Aikaikkuna: Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit

Postnatal hour when the first skin-to-skin contact will occur in the neonatal care unit
Practice of skin-to-skin contact in the neonatal intensive care unit (NICU) during the first week of life
Aikaikkuna: During the first 7 days of the stay in the neonatal care unit

Frequency of skin-to-skin contact (Postnatal day and hour), length of each skin-to-skin contact, which parent involves in each skin-to-skin contact episode.

During the first 7 days of the stay in the neonatal care unit
Quality of parental bond
Aikaikkuna: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Assessment through a maternal questionnaire: Mother-to-Infant Bonding Scale (MIBS) questionnaire (Mother-to-infant bonding scale - Taylor, 2005). Only the infant's mother will be invited to fill out this questionnaire.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Parental stress
Aikaikkuna: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Parental stress assessed by Perceived Stress Scale (PSS) - Neonatal Intensive Care Unit (NICU) questionnaire (Perceived Stress Scale Neonatal Intensive Care Unit - Miles, 1993). The infant's mother and father will be invited to fill out this questionnaire.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Parental post-traumatic stress disorder
Aikaikkuna: At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Parental post-traumatic stress disorder assessed by Perinatal Post traumatic stress disorder Questionnaire (PPQ) - DEMIER, 1996). The infant's mother and father will be invited to fill out this questionnaire.

At the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30
Infant growth: Weight
Aikaikkuna: At birth and weight at the postmenstrual age of 36 weeks

Weight at birth and at the postmenstrual age of 36 weeks

At birth and weight at the postmenstrual age of 36 weeks
Infant growth: Height
Aikaikkuna: At birth and at the postmenstrual age of 36 weeks

Height at birth and at the postmenstrual age of 36 weeks

At birth and at the postmenstrual age of 36 weeks
Infant growth: Head circumference
Aikaikkuna: At birth and at the postmenstrual age of 36 weeks

Head circumference at birth and at the postmenstrual age of 36 weeks

At birth and at the postmenstrual age of 36 weeks
Neonatal morbidity and mortality at the postmenstrual age of 36 weeks
Aikaikkuna: At the postmenstrual age of 36 weeks

Death

  • Intraventricular hemorrhage (maximal grade),
  • Periventricular leukomalacia, Necrotizing enterocolitis (> stade 2 of the Bell classification),
  • Neonatal surgery,
  • Early onset sepsis (onset before postnatal day 2 and > 3 days of intravenous antibiotherapy),
  • Late onset sepsis (Blood culture positive, number of events),
  • Number of red blood cell transfusions,
  • Duration of mechanical ventilation (days).
  • Severe bronchopulmonary dysplasia,
  • Retinopathy of prematurity that requires laser photocoagulation or intravitreal injection of proangiogenic factor,
  • Length of stay in neonatal intensive care unit (days).
At the postmenstrual age of 36 weeks
Modalities of breastfeeding
Aikaikkuna: During the NICU stay: infant postnatal day

First breastfeeding attempt in the neonatal intensive care unit (NICU)

During the NICU stay: infant postnatal day
Modalities of breastfeeding
Aikaikkuna: At the postmenstrual age of 36 weeks

Presence of complete or partial breastfeeding at the postmenstrual age of 36 weeks

At the postmenstrual age of 36 weeks
Mode of infant feeding at the postmenstrual age of 36 weeks
Aikaikkuna: At the postmenstrual age of 36 weeks

Modes of infant feeding that include breastfeeding, breastmilk given through a bottle, artificial formula

At the postmenstrual age of 36 weeks

Muut tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Self-questionnaires to study parents' experience of their infant hospitalization
Aikaikkuna: 2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Ancillary study: Self-questionnaires to study parents' experience of their infant hospitalization to assess stress at different times.

2 time points: i) Between the infant postnatal day 3 and postnatal day 7, and ii) at the infant postnatal day 30 or at the end of the stay in the NICU if this event occur before the postnatal day 30

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Opintojohtaja: Nolwenn CLENET, University Hospital, Tours

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Keskiviikko 3. toukokuuta 2023

Ensisijainen valmistuminen (Todellinen)

Tiistai 10. maaliskuuta 2026

Opintojen valmistuminen (Todellinen)

Keskiviikko 15. huhtikuuta 2026

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 23. maaliskuuta 2023

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Torstai 6. huhtikuuta 2023

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 19. huhtikuuta 2023

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Maanantai 9. marraskuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 4. marraskuuta 2026

Viimeksi vahvistettu

Sunnuntai 1. marraskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Muita asiaankuuluvia MeSH-ehtoja

Muut tutkimustunnusnumerot

  • DR210297

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa